| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | — |
100% | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 20 | ₹30,000 |
| Retail (Max — 13 Lots) | 13 | 130 | ₹195,000 |
| S-HNI (Min — 14 Lots) | 14 | 140 | ₹210,000 |
| B-HNI (Min — 68 Lots) | 68 | 680 | ₹1,020,000 |
Gland Pharma Ltd. is proposing an IPO on NSE & BSE under the Mainboard category.
Opens 09 Nov 2020, closes 11 Nov 2020. Listing: 19 Nov 2020. Apply via ASBA or UPI.
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Gland Pharma Ltd. IPO is subscribed 1.00 times by Nov 11, 2020. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Gland Pharma Ltd. IPO retail category is subscribed 1.00 times as of 11 Nov 2020. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 09 Nov 2020 and closes 11 Nov 2020. Min investment: ₹15,000 (1 lot = 10 shares). UPI mandate: 5:00 PM on 11 Nov 2020.
The Gland Pharma Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 17 Nov 2020. Refunds: on 18 Nov 2020.
The Gland Pharma Ltd. IPO listing date is 19 Nov 2020, Thursday. Listed on: NSE & BSE. Issue price: ₹1,500. Estimated listing: ₹1,500. GMP: NIL.
The Gland Pharma Ltd. IPO closes on 11 Nov 2020, Wednesday. UPI mandate: 5:00 PM on 11 Nov 2020. Allotment: 17 Nov 2020. Listing: 19 Nov 2020.